Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Archives of Internal Medicine

• Publication date

  2008-10-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/archinte.168.18.2000PMID 18852401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• General practitioners’ perceptions of introducing near-patient testing for common infections into routine primary care: A qualitative study

  2008cited by this paper
• Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data.

  2008cited by this paper
• Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

  2008cited by this paper
• Antibiotic use for emergency department patients with upper respiratory infections: prescribing practices, patient expectations, and patient satisfaction.

  2007cited by this paper
• Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.

  2007cited by this paper
• Prevalence and influence of diagnostic tests for acute respiratory tract infections in primary care.

  2006cited by this paper
• Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.

  2006cited by this paper
• Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland.

  2006cited by this paper
• Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

  2006cited by this paper
• Pneumonia: update on diagnosis and management

  2006cited by this paper
• Communication training and antibiotic use in acute respiratory tract infections. A cluster randomised controlled trial in general practice.

  2006cited by this paper
• Trends in antibiotic prescribing for adults in the United States—1995 to 2002

  2005cited by this paper
• BMC Family Practice BioMed Central Study protocol

  2005cited by this paper
• Erratum: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis (Clinical Infectious Diseases (July 15, 2004) 39 (206-217))

  2005cited by this paper
• Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial.

  2005cited by this paper
• Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review

  2005cited by this paper
• Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

  2005cited by this paper
• Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

  2004cited by this paper
• Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.

  2004cited by this paper
• Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors.

  2004cited by this paper
• Changing Use of Antibiotics in Community-Based Outpatient Practice, 19911999

  2003cited by this paper
• The future diagnostic role of procalcitonin levels: the need for improved sensitivity.

  2003cited by this paper
• Evidence base of clinical diagnosis: Rational, cost effective use of investigations in clinical practice.

  2002cited by this paper
• Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems

  2002cited by this paper
• Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial.

  2002cited by this paper
• A randomised controlled trial of delayed antibiotic prescribing as a strategy for managing uncomplicated respiratory tract infection in primary care.

  2001cited by this paper
• Principles of Appropriate Antibiotic Use for Acute Rhinosinusitis in Adults: Background

  2001cited by this paper
• Excessive antibiotic use for acute respiratory infections in the United States.

  2001cited by this paper
• Principles of Appropriate Antibiotic Use for Treatment of Acute Respiratory Tract Infections in Adults: Background, Specific Aims, and Methods

  2001cited by this paper
• Principles of Appropriate Antibiotic Use for Acute Pharyngitis in Adults: Background

  2001cited by this paper
• Evidence Base for Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  2001cited by this paper
• Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

  2000cited by this paper
• Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice.

  2000cited by this paper
• The culture of antibiotics.

  1999cited by this paper
• The cost of antibiotics in treating upper respiratory tract infections in a medicaid population.

  1998influential reference
• Procalcitonin and its Component Peptides in Systemic Inflammation: Immunochemical Characterization

  1997cited by this paper
• Finance, not learning needs, makes general practitioners attend courses: a database survey

  1997cited by this paper
• Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria.

  1996cited by this paper
• Trials to assess equivalence: the importance of rigorous methods

  1996cited by this paper
• Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey.

  1996influential reference
• Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children.

  1995cited by this paper
• Sore throat, antibiotics, and progression to meningococcal disease.

  1995cited by this paper
• Uncomfortable prescribing decisions: a critical incident study.

  1992cited by this paper

• Guidelines for the Initial Assessment of Respiratory Distress in the Emergency Department.

  2026cites this paper
• The Influence of the Procalcitonin Method in Detecting Paediatrics Infections

  2026cites this paper
• A short-term cross-sectional retrospective study on procalcitonin as a diagnostic aid for various infectious diseases

  2025cites this paper
• Procalcitonin in the management of lower respiratory tract infection and sepsis.

  2025cites this paper
• A genome- and phenome-wide association study of plasma procalcitonin concentrations in individuals of European ancestry

  2025cites this paper
• Heparin Binding Protein in Sepsis—A Comprehensive Overview of Pathophysiology, Clinical Usage and Utility as Biomarker

  2025influential citation
• Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review

  2024cites this paper
• Physiologic changes of pregnancy and considerations for screening and diagnosis of sepsis.

  2024cites this paper
• Inflammatory biomarker-based clinical practice in patients with pneumonia: A systematic review of randomized controlled trials

  2024cites this paper
• Procalcitonin Guided Antibiotic Stewardship

  2024cites this paper
• Evaluation of Serial Procalcitonin Levels for the Optimization of Antibiotic Use in Non-Critically Ill COVID-19 Patients

  2024cites this paper
• Procalcitonin-guided antibiotic treatment in patients with cancer: a patient-level meta-analysis from randomized controlled trials

  2024cites this paper
• PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial

  2024cites this paper
• Procalcitonin levels in pregnancy: A systematic review and meta‐analysis of observational studies

  2023cites this paper
• PROCALCITONIN GUIDED ANTIBIOTIC STEWARDSHIP: A BALKAN EXPERT CONSENSUS STATEMENT

  2023cites this paper
• Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival—a systematic review and meta-analysis

  2023cites this paper
• Clinical Uncertainty Influences Antibiotic Prescribing for Upper Respiratory Tract Infections: A Qualitative Study of Township Hospital Physicians and Village Doctors in Rural Shandong Province, China

  2023cites this paper
• Exploration of the Acceptance of the Use of Procalcitonin Point-of-Care Testing and Lung Ultrasonography by General Practitioners to Decide on Antibiotic Prescriptions for Lower Respiratory Infections: A Qualitative Study

  2023cites this paper
• Point-of-care multiplex molecular diagnosis coupled with procalcitonin-guided algorithm for antibiotic stewardship in lower respiratory tract infection: a randomized controlled trial.

  2023cites this paper
• AACC Guidance Document on the Clinical Use of Procalcitonin.

  2023cites this paper
• Evaluation of pharmacist guided intervention using procalcitonin and respiratory virus testing.

  2023cites this paper
• Procalcitonin As a Metric Septic Inflammatory Biomarker in Young Calves

  2023cites this paper
• Point-of-care procalcitonin testing for lower respiratory tract infection in pulmonary outpatient care has limited value

  2023cites this paper
• Predictive values of procalcitonin for coinfections in patients with COVID-19: a systematic review and meta-analysis

  2023cites this paper
• Antimicrobial Use in Positive Respiratory Viral Panel: Impact of Procalcitonin Use and Antimicrobial Stewardship

  2022cites this paper
• Association of Interprofessional Discharge Planning Using an Electronic Health Record Tool With Hospital Length of Stay Among Patients with Multimorbidity

  2022cites this paper
• Comparing Serum Procalcitonin Levels Between Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Patients with Acute Exacerbation of Asthma

  2022cites this paper
• Procalcitonin-guided antibiotic therapy for pediatrics with infective disease: A updated meta-analyses and trial sequential analysis

  2022cites this paper
• Procalcitonin levels in COVID-19 patients in a tertiary care center

  2022cites this paper
• Inflammation in COVID-19: A Risk for Superinfections

  2022cites this paper
• Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.

  2022cites this paper
• Veteriner Hekimlikte Prokalsitoninin Tanı, Ayırıcı Tanı ve Prognozdaki Önemi

  2022cites this paper
• The Procalcitonin-guided Antibiotics in Respiratory Infections (PARI) project in general practice – a study protocol

  2022influential citation
• Circulating miR-15b, Annexin A1, procalcitonin and interleukin-6 levels differentiate children with metabolically unhealthy obesity from those with metabolically healthy obesity: A case-control study

  2022cites this paper
• Frequency and Types of Healthcare Encounters in the Week Preceding a Sepsis Hospitalization: A Systematic Review

  2022cites this paper
• Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill

  2022cites this paper
• Utilizing procalcitonin in a clinical setting to help differentiate between aspiration pneumonia and aspiration pneumonitis.

  2022cites this paper
• Procalcitonin use for the screening of bacterial infections in pregnant women in the emergency ward: a prospective study.

  2021cites this paper
• Impact of Diagnostic Testing on Pediatric Patients With Pharyngitis: Evidence From a Large Health Plan

  2021cites this paper
• Procalcitonin Serum Level in Patients Aged 3-36 Months With Focal Fever Referred to Hospitals in Western Iran in 2020

  2021cites this paper
• Diagnostic Accuracy and Prognostic Value of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Septic Patients outside the Intensive Care Unit

  2021cites this paper
• Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial

  2021cites this paper
• OP-JACR210153 1..3

  2021cites this paper
• CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia

  2021cites this paper
• Does diagnostic uncertainty increase antibiotic prescribing in primary care?

  2021cites this paper
• C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19

  2021cites this paper
• Study Designs: Diagnostic Studies

  2021cites this paper
• Clinical sign and biomarker-based algorithm to identify bacterial pneumonia among outpatients with lower respiratory tract infection in Tanzania

  2021cites this paper
• Point-of-care tests to inform antibiotic prescribing

  2021cites this paper
• Interventions to Influence the Use of Antibiotics for Acute Upper Respiratory Tract Infections

  2021cites this paper
• Diagnostic Value of Procalcitonin in Transplant Patients Receiving Immunosuppressant Drugs.

  2021cites this paper
• Biomarkers in intensive care: C-reactive protein and procalcitonin

  2020cites this paper
• Can Procalcitonin Improve Antibiotic Stewardship for Late-Onset Sepsis Evaluations in Neonates?

  2020cites this paper
• A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine

  2020cites this paper
• A Comparison of Acute Physiology and Chronic Health Evaluation II Score and Serum Procalcitonin Change for Predicting Mortality in Acute Pancreatitis

  2020cites this paper
• Antimicrobial stewardship in the outpatient setting: A review and proposed framework

  2020cites this paper
• Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting

  2020cites this paper
• The relationship between body mass index and N-terminal pro-B-type natriuretic peptide in community-acquired pneumonia

  2020cites this paper
• Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease

  2020cites this paper
• Utility of Procalcitonin Test in Appropriate Antibacterial Choice: Retrospective Evaluation

  2020cites this paper
• Rapid Diagnosis of Respiratory Tract Infections Using a Point-of-Care Platform Incorporating a Clinical Decision Support Algorithm

  2020cites this paper
• PRESEPSIN: NEW BIOMAKER TO EVALUATE EMPIRICAL ANTIBIOTIC THERAPY OUTCOME IN SEPTIC CONDITION

  2020cites this paper
• A RESEARCH STUDY PROCALCITON TO START AND STOP ANTIBIOTICS IN ACUTE RESPIRATORY TRACT INFECTIONS

  2020cites this paper
• Evaluation of Serum Amyloid A and Procalcitonin in Some Inflammatory Diseases of Cattle

  2020cites this paper
• Clinical Utility of Procalcitonin-Guided Antibiotic Discontinuation in Hospitalized Pneumonia Patients in Daily Clinical Practice

  2020cites this paper
• Best diagnostic accuracy of sepsis combining SIRS criteria or qSOFA score with Procalcitonin and Mid-Regional pro-Adrenomedullin outside ICU

  2020cites this paper
• Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial

  2019cites this paper
• PCT

  2019cites this paper
• Serum Procalcitonin Level as a Predictor of Bacterial Infection in Patients with COPD Exacerbation

  2019cites this paper
• Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use

  2019cites this paper
• Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.

  2019cites this paper
• Serum Procalcitonin Levels in Chronic Obstructive Pulmonary Disease Patients in North Indian Population

  2019cites this paper
• Procalcitonin: Between evidence and critical issues.

  2019cites this paper
• Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use

  2019cites this paper
• Stellenwert des Procalcitonins als Sepsismarker

  2019cites this paper
• The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach.

  2019cites this paper
• Novel approaches to decrease inappropriate ambulatory antibiotic use

  2019cites this paper
• Biomarkers of Acute Lung Injury The Individualized Approach: for Phenotyping, Risk Stratification and Treatment Surveillance

  2019cites this paper
• [Place of biomarkers in the management of pulmonary infections].

  2019cites this paper
• The Effects Of De-Escalation Under the Guidance of Procalcitonin in Sepsis

  2019cites this paper
• [Short course antibiotic treatment during community acquired pneumonia: Review of the literature and perspectives].

  2019cites this paper
• Is Interleukin-6 a better predictor of successful antibiotic therapy than procalcitonin and C-reactive protein? A single center study in critically ill adults

  2019cites this paper
• Outpatient management of community-acquired pneumonia

  2019cites this paper
• Uso de procalcitonina sérica e proteína C‐reativa na avaliação de infecção bacteriana em casos de psoríase pustulosa generalizada

  2019cites this paper
• Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.

  2019cites this paper
• The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections

  2019cites this paper
• Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy

  2019cites this paper
• Serum procalcitonin and C-reactive protein in the evaluation of bacterial infection in generalized pustular psoriasis

  2019cites this paper
• Procalcitonin in acute infections: from the research laboratory to clinical impact—new perspectives of biomarker use

  2019cites this paper
• Use of clinical algorithms and rapid influenza testing to manage influenza-like illness: a cost-effectiveness analysis in Sri Lanka

  2019cites this paper
• The Case of Procalcitonin for Lower Respiratory Tract Infections

  2019cites this paper
• Procalcitonin and antibiotics in moderate–severe acute exacerbation of chronic obstructive pulmonary disease: to use or not to use

  2019cites this paper
• Outpatient management of community-acquired pneumonia

  2018cites this paper
• Procalcitonin and Other Host-Response-Based Biomarkers for Evaluation of Infection and Guidance of Antimicrobial Treatment

  2018cites this paper
• of Groningen Plasma Procalcitonin Is Associated with Obesity , Insulin Resistance , and the Metabolic Syndrome

  2018cites this paper
• Procalcitonin-guided antibiotic therapy: an expert consensus

  2018cites this paper
• Outpatient Antibiotic Stewardship: A Growing Frontier—Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use

  2018cites this paper
• Procalcitonin-Guided Therapy for Reduction of Antibiotic Use in Patients with Bronchiolitis

  2018cites this paper
• Procalcitonin unter’m Schutzschirm

  2018cites this paper
• Procalcitonin as a Biomarker in Rhinosinusitis: A Systematic Review

  2018cites this paper